554 related articles for article (PubMed ID: 11558875)
21. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
[TBL] [Abstract][Full Text] [Related]
22. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases.
Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658
[No Abstract] [Full Text] [Related]
23. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
Otte HG; Stieler W; Anton-Lamprecht I
Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
[TBL] [Abstract][Full Text] [Related]
24. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
[TBL] [Abstract][Full Text] [Related]
25. [Generalized dystrophic epidermolysis bullosa and development of squamous cell carcinoma].
Petersen RB; Bonde CT; Schmidt G
Ugeskr Laeger; 2010 Nov; 172(47):3267-8. PubMed ID: 21092724
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma and a squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Chorny JA; Shroyer KR; Golitz LE
Arch Dermatol; 1993 Sep; 129(9):1212. PubMed ID: 8363416
[No Abstract] [Full Text] [Related]
27. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
[TBL] [Abstract][Full Text] [Related]
28. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
Yuen WY; Jonkman MF
J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
[TBL] [Abstract][Full Text] [Related]
29. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
30. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
[TBL] [Abstract][Full Text] [Related]
31. [Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa].
Bourrat E
Soins; 2023 Nov; 68(880):36-38. PubMed ID: 37931996
[TBL] [Abstract][Full Text] [Related]
32. Verruciform xanthoma developing in recessive dystrophic epidermolysis bullosa: A sheep in wolf's clothing.
Curto-Barredo L; Segura S; Barranco C; Bellosillo B; Lloreta J; Toll A; Sanmartín O; Pujol RM
Am J Dermatopathol; 2014 Jun; 36(6):506-9. PubMed ID: 23676320
[TBL] [Abstract][Full Text] [Related]
33. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Gayathri E; Anbukkarasi K; Lilly SM
Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
[TBL] [Abstract][Full Text] [Related]
34. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients.
Buonocore SD; Ariyan S
Ann Plast Surg; 2009 Sep; 63(3):297-9. PubMed ID: 19692898
[TBL] [Abstract][Full Text] [Related]
35. Squamous cell carcinoma developing in epidermolysis bullosa dystrophica.
Yoshioka K; Kono T; Kitajima J; Nakagawa K; Yashiro N; Taniguchi S; Furukawa M; Hamada T
Int J Dermatol; 1991 Oct; 30(10):718-21. PubMed ID: 1955228
[TBL] [Abstract][Full Text] [Related]
36. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Arbiser JL; Fine JD; Murrell D; Paller A; Connors S; Keough K; Marsh E; Folkman J
Mol Med; 1998 Mar; 4(3):191-5. PubMed ID: 9562977
[TBL] [Abstract][Full Text] [Related]
37. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
[TBL] [Abstract][Full Text] [Related]
38. Age and etiology of childhood epidermolysis bullosa mortality.
Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
[TBL] [Abstract][Full Text] [Related]
40. Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.
Sans-DeSanNicolas L; Caratú G; Vidal-Cortés O; Sanchez-Redondo S; Ferrer B; Mancuso F; González-Sanchez E; Pérez-Alea M; McGrail K; Hernandez-Losa J; Bodet D; Vivancos A; Garcia-Patos V; Recio JA
J Invest Dermatol; 2018 Jun; 138(6):1423-1427. PubMed ID: 29291383
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
